Rojas-Campos Enrique, Alcántar-Medina Mario, Cortés-Sanabria Laura, Martínez-Ramírez Héctor R, Camarena José L, Chávez Salvador, Flores Antonio, Nieves Juan J, Monteón Francisco, Gómez-Navarro Benjamin, Cueto-Manzano Alfonso M
Unidad de Investigación Médica en Enfermedades Renales, UMAE, Hospital de Especialidades, CMNO.
Rev Invest Clin. 2007 May-Jun;59(3):184-91.
In Mexico, CAPD survival has been analyzed in few studies from the center of the country. However, there are concerns that such results may not represent what occurs in other province centers of our country, particularly in our geographical area.
To evaluate the patient and technique survival on CAPD of a single center of the west of Mexico, and compare them with other reported series.
Retrospective cohort study.
Tertiary care, teaching hospital located in Guadalajara, Jalisco.
Patients from our CAPD program (1999-2002) were retrospectively studied. Interventions. Clinical and biochemical variables at the start of dialysis and at the end of the follow-up were recorded and considered in the analysis of risk factors.
Endpoints were patient (alive, dead or lost to follow-up) and technique status at the end of the study (June 2002).
49 patients were included. Mean patient survival (+/- SE) was 3.32 +/- 0.22 years (CI 95%: 2.9-3.8 years). Patients in the present study were younger (39 +/- 17yrs), had larger body surface area (1.72 +/- 0.22 m2), lower hematocrit (25.4 +/- 5.2%), albumin (2.6 +/- 0.6g/dL), and cholesterol (173 +/- 44 mg/dL), and higher urea (300 +/- 93 mg/dL) and creatinine (14.9 +/- 5.6 mg/ dL) than those in other Mexican series. In univariate analysis, the following variables were associated (p < 0.05) to mortality: pre-dialysis age and creatinine clearance, and serum albumin and cholesterol at the end of follow-up. In multivariate analysis, only pre-dialysis creatinine clearance (RR 0.66, p = 0.03) and age (RR 1.08, p = 0.005) significantly predicted mortality. Mean technique survival was 2.83 +/- 0.24 years (CI 95%: 2.4-3.3). Pre-dialysis age (p < 0.05), peritonitis rate (p < 0.05), and serum phosphorus at the end of follow-up (p < 0.05) were associated with technique failure in univariate analysis, while in multivariate analysis, only pre-dialysis age (RR 1.07, p = 0.001) and peritonitis rate (RR 481, p < 0.0001) were technique failure predictors.
Patients from this single center of the west of Mexico were younger, had higher body surface area and initiated peritoneal dialysis with a more deteriorated general status than patients reported in other Mexican series; in spite of the latter, patient and technique survival were not different. In our setting, pre-dialysis older age and lower CrCl significantly predicted mortality, while older predialysis age and higher peritonitis rate predicted technique failure.
在墨西哥,仅对该国中部地区的少数研究分析了持续性非卧床腹膜透析(CAPD)的生存率。然而,有人担心这些结果可能无法代表我国其他省份中心地区的情况,尤其是我们所在的地理区域。
评估墨西哥西部一个中心的CAPD患者生存率和技术生存率,并与其他报道的系列进行比较。
回顾性队列研究。
位于哈利斯科州瓜达拉哈拉的三级护理教学医院。
对我们CAPD项目(1999 - 2002年)的患者进行回顾性研究。干预措施。记录透析开始时和随访结束时的临床和生化变量,并在危险因素分析中予以考虑。
研究结束时(2002年6月)的终点为患者状态(存活、死亡或失访)和技术状态。
纳入49例患者。患者平均生存时间(±标准误)为3.32±0.22年(95%置信区间:2.9 - 3.8年)。本研究中的患者更年轻(39±17岁),体表面积更大(1.72±0.22平方米),血细胞比容更低(25.4±5.2%),白蛋白(2.6±0.6克/分升)和胆固醇(173±44毫克/分升)更低,尿素(300±93毫克/分升)和肌酐(14.9±5.6毫克/分升)比其他墨西哥系列研究中的患者更高。单因素分析中,以下变量与死亡率相关(p<0.05):透析前年龄、肌酐清除率、随访结束时的血清白蛋白和胆固醇。多因素分析中,只有透析前肌酐清除率(相对危险度0.66,p = 0.03)和年龄(相对危险度1.08,p = 0.005)显著预测死亡率。平均技术生存时间为2.83±0.24年(95%置信区间:2.4 - 3.3年)。单因素分析中,透析前年龄(p<0.05)、腹膜炎发生率(p<0.05)和随访结束时的血清磷(p<0.05)与技术失败相关,而多因素分析中,只有透析前年龄(相对危险度1.07,p = 0.001)和腹膜炎发生率(相对危险度481,p<0.0001)是技术失败的预测因素。
墨西哥西部这个单一中心的患者比其他墨西哥系列研究中报道的患者更年轻,体表面积更大,开始腹膜透析时全身状况更差;尽管如此,患者生存率和技术生存率并无差异。在我们的研究环境中,透析前年龄较大和肌酐清除率较低显著预测死亡率,而透析前年龄较大和腹膜炎发生率较高预测技术失败。